Based on these facts and aiming at understanding some aspects of the IFN-γ/IL-10 profile in the different clinical presentations and tissue compartment of human sporotrichosis, we quantified the systemic and in situ IFN-γ and IL-10 expressions by immunohistochemistry and Elispot assay. This evidence concerns the gene IFNG and sporotrichosis.